CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ·Healthcare·Biotechnology
$5.82
+1.22%
Mkt Cap $1.74M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$0.50
Range $0.50 – $0.50
Implied Upside
-91.4%
Consensus $0.50 vs current $5.82
NASDAQ·Healthcare·Biotechnology
$5.82
+1.22%
Mkt Cap $1.74M
No recent rating data.
Price Target (1 analysts)
$0.50
Range $0.50 – $0.50
-91.4%
Consensus $0.50 vs current $5.82